Your browser doesn't support javascript.
Molecular diagnostics in the era of COVID-19.
Jayakody, Harindi; Kiddle, Guy; Perera, Semali; Tisi, Laurence; Leese, Hannah S.
  • Jayakody H; Materials for Health Lab, Department of Chemical Engineering, University of Bath, Bath, UK. h.s.leese@bath.ac.uk.
  • Kiddle G; Erba Molecular, Ely, Cambridgeshire, UK. l.tisi@erbamannheim.com.
  • Perera S; Erba Molecular, Ely, Cambridgeshire, UK. l.tisi@erbamannheim.com.
  • Tisi L; Materials for Health Lab, Department of Chemical Engineering, University of Bath, Bath, UK. h.s.leese@bath.ac.uk.
  • Leese HS; Erba Molecular, Ely, Cambridgeshire, UK. l.tisi@erbamannheim.com.
Anal Methods ; 13(34): 3744-3763, 2021 09 02.
Article in English | MEDLINE | ID: covidwho-1454826
ABSTRACT
As the COVID-19 pandemic continues to escalate globally and acquires new mutations, accurate diagnostic technologies continue to play a vital role in controlling and understanding the epidemiology of this disease. A plethora of technologies have enabled the diagnosis of individuals, informed clinical management, aided population-wide screening to determine transmission rates and identified cases within the wider community and high-risk settings. This review explores the application of molecular diagnostics technologies in controlling the spread of COVID-19, and the key factors that affect the sensitivity and specificity of the tests used.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Diagnostic study / Prognostic study Limits: Humans Language: English Journal: Anal Methods Year: 2021 Document Type: Article Affiliation country: D1AY00947H

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Type of study: Diagnostic study / Prognostic study Limits: Humans Language: English Journal: Anal Methods Year: 2021 Document Type: Article Affiliation country: D1AY00947H